top of page

Committed to Health

About

Transforming the future of health care through innovative life science solutions and strategic partnerships.

CureOmics is dedicated to improve therapeutic and preventive options for unmet health care needs.

 

Our research is focused on the development of innovative therapies and differentiated generic pharmaceuticals, as well as nutraceuticals and cosmeceuticals

Petrischale

Research and Product Development

From research through product development, we advance pharmaceutical and specialized generic products across diverse therapeutic areas, with a particular focus on gastroenterology, metabolism, oncology and dermatology. Our capabilities also extend to selected ingredients and nutraceutical solutions.

Rosa Ölblasen

1

Pharmaceuticals

OUR RESEARCH & PARTNERED PROGRAMS

Our teams’s expertise is deeply rooted in pharmaceutical sciences, where we focus on advancing our lead pipeline program. 

Alongside our in-house innovations, we partner with third-party pharmaceutical companies to co-develop and register innovative and selected generic drugs. This dual approach allows us to prioritize our own research while also expanding our impact through strategic partnerships. 

2

Nutraceuticals

OUR RESEARCH & PRODUCT PORTFOLIO

CureOmics is developing a new ingredients that can support various aspects of health, particularly in aging, inflammation, and metabolic function.

In parallel, we have a portfolio of clinically validated next-generation nutraceuticals for health care and preventive care. These products are specifically formulated to support joint health, reduce inflammation, and optimize metabolism. Additionally, our nutraceuticals also target gut health, promoting a balanced microbiome and gastric function.

3

Cosmeceuticals

OUR INNOVATION & PRODUCT PORTFOLIO

Our company has built its dermatology-research around the development of innovative and new cosmetic ingredients with the ability to counteract the age-related deterioration of skin function. Our first-to-market ingredient provides versatile formulation options, making it adaptable to a wide range of skincare products. Its mechanism of action has been clinically proven to enhance cellular function relevant for both the dermis and epidermis, ensuring holistic skin support. Through this advancement, we aim to set new standards in anti-aging skincare solutions.

We complement this innovation with a product portfolio of best-in-class clinically tested cosmetic ingredients.

Face Serum

Partnering, Business Development and Licensing 

Accelerating Innovation Through Strategic Alliances

Business Development & Licensing 

With deep experiences in business development, licensing, intellectual property and regulatory affairs, CureOmics works with third parties for efficient development, marketing and licensing of generic and innovative products.

Partnering​

CureOmics has formed strategic partnerships with corporates to develop innovative and specialised generic drug products, nutraceuticals and cosmeceuticals. These alliances enable us to leverage our expertise for ensuring efficient and high-quality product development, IP strategies, product registration and commercialisation. 

We are continually interested in hearing from companies seeking to out-license or co-develop products and in exploring how our expertise as a service provider can help advance these opportunities.

Please reach out to us: info@cureomics.com

Alle Hände rein

What We Stand For

Innovation, Health, Community.

CureOmics is committed to improve people's lives.

We achieve this through a dedicated focus on scientific and technological advances and translating this knowledge into innovative and differentiated generic pharmaceuticals, nutraceuticals and cosmeceuticals.

We believe in the power of community and are committed to building trust-based, long-lasting relationships with our partners, clients, employees, vendors and shareholders. 

Wissenschaft
DNA

CureOmics in Numbers

75

Employees

$100

In Investments

224

Partners Worldwide

15

Publications

25

Ongoing Research Programs

Join Our Team

We’re looking for highly-motivated and talented people to join our innovative team. Submit your application today.

New job opening coming soon

Zug, CH

News

CureOmics joins the 13th Aging Research Meeting

 

Aging Research and Drug Discovery (ARDD)

Copenhagen, Denmark
August 2026

CureOmics joins VitaFood Europe

 

 

Barcelona, Spain
May 2026

CureOmics joins CPHI Europe

 

 

Milan, Italy
October 2026

Join The CureOmics Newsletter

Be the first to receive the latest news and updates.

bottom of page